URS
XLRN

Utah Retirement Systems’s Acceleron Pharma XLRN Stock Holding History

Utah Retirement Systems’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,700
Closed -$465K – 1012
2021
Q3 		$465K Hold
2,700
– – 0.01% 856
2021
Q2 		$339K Hold
2,700
– – ﹤0.01% 886
2021
Q1 		$366K Hold
2,700
– – 0.01% 846
2020
Q4 		$345K Buy
2,700
+500
+23% +$58.6K ﹤0.01% 846
2020
Q3 		$248K Buy
+2,200
New +$219K ﹤0.01% 870

Utah Retirement Systems's XLRN Position: Q4 2021 in Review

Utah Retirement Systems sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,700 shares — an estimated $465K sold.

Utah Retirement Systems first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $465K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Utah Retirement Systems reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Utah Retirement Systems sold 2,700 Acceleron Pharma shares in Q4 2021, an estimated $465K.
  • Utah Retirement Systems first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
  • Utah Retirement Systems's Acceleron Pharma position peaked at $465K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Utah Retirement Systems's 13F filing for Q4 2021, filed 14 Feb 2022.